Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients

被引:6
|
作者
Morath, Christian [1 ,2 ]
Schaier, Matthias [1 ,2 ]
Ibrahim, Eman [3 ,4 ]
Wang, Lei [2 ,5 ]
Kleist, Christian [3 ,6 ]
Opelz, Gerhard [3 ]
Suesal, Caner [3 ,7 ]
Ponath, Gerald [1 ,2 ]
Aly, Mostafa [1 ,3 ,8 ]
Alvarez, Cristiam M. [9 ]
Kaelble, Florian [1 ]
Speer, Claudius [1 ]
Benning, Louise [1 ]
Nusshag, Christian [1 ]
da Silva, Luiza Pego [1 ]
Sommerer, Claudia [1 ]
Hueckelhoven-Krauss, Angela [5 ]
Czock, David [10 ]
Mehrabi, Arianeb [11 ]
Schwab, Constantin [12 ]
Waldherr, Ruediger [12 ]
Schnitzler, Paul [13 ]
Merle, Uta [14 ]
Thuong Hien Tran [3 ]
Scherer, Sabine [3 ]
Boehmig, Georg A. [15 ]
Mueller-Tidow, Carsten [5 ]
Reiser, Jochen [16 ]
Zeier, Martin [1 ]
Schmitt, Michael [5 ]
Terness, Peter [3 ]
Schmitt, Anita [2 ,5 ]
Daniel, Volker [3 ]
机构
[1] Heidelberg Univ Hosp, Dept Nephrol, Neuenheimer Feld 162, D-69120 Heidelberg, Germany
[2] TolerogenixX GmbH, Heidelberg, Germany
[3] Heidelberg Univ Hosp, Inst Immunol, Heidelberg, Germany
[4] Assiut Univ, South Egypt Canc Inst, Clin Pathol Dept, Assiut, Egypt
[5] Heidelberg Univ Hosp, Dept Hematol Oncol & Rheumatol, Heidelberg, Germany
[6] Heidelberg Univ Hosp, Dept Nucl Med, Heidelberg, Germany
[7] Kog Univ, Transplant Immunol Res Ctr Excellence, Istanbul, Turkiye
[8] Assiut Univ, Internal Med Dept, Nephrol Unit, Assiut, Egypt
[9] Univ Antioquia, Fac Med, Cellular Immunol & Immunogenet Grp, Medellin, Colombia
[10] Heidelberg Univ Hosp, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany
[11] Heidelberg Univ Hosp, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany
[12] Heidelberg Univ Hosp, Inst Pathol, Heidelberg, Germany
[13] Heidelberg Univ Hosp, Ctr Infect Dis, Virol, Heidelberg, Germany
[14] Heidelberg Univ Hosp, Dept Gastroenterol, Heidelberg, Germany
[15] Med Univ Vienna, Dept Med 3, Div Nephrol & Dialysis, Vienna, Austria
[16] Rush Univ, Dept Med, Chicago, IL 60612 USA
来源
关键词
clinical trial; immunosuppression; kidney transplantation; regulatory B lymphocytes; tolerance; MITOMYCIN-C; ALLOGRAFT SURVIVAL; BLOOD-CELLS; OPERATIONAL TOLERANCE; DENDRITIC CELLS; SIGNATURE; REJECTION; PROLONGATION; INHIBITION; GENERATION;
D O I
10.1681/ASN.2022020210
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
BackgroundWe recently demonstrated that donor-derived modified immune cells (MICs)-PBMCs that acquire immunosuppressive properties after a brief treatment-induced specific immunosuppression against the allogeneic donor when administered before kidney transplantation. We found up to a 68-fold increase in CD19(+)CD24(hi)CD38(hi) transitional B lymphocytes compared with transplanted controls.MethodsTen patients from a phase 1 clinical trial who had received MIC infusions before kidney transplantation were followed to post-transplant day 1080.ResultsPatients treated with MICs had a favorable clinical course, showing no donor-specific human leukocyte antigen antibodies or acute rejections. The four patients who had received the highest dose of MICs 7 days before surgery and were on reduced immunosuppressive therapy showed an absence of in vitro lymphocyte reactivity against stimulatory donor blood cells, whereas reactivity against third party cells was preserved. In these patients, numbers of transitional B lymphocytes were 75-fold and seven-fold higher than in 12 long-term survivors on minimal immunosuppression and four operationally tolerant patients, respectively (P<0.001 for both). In addition, we found significantly higher numbers of other regulatory B lymphocyte subsets and a gene expression signature suggestive of operational tolerance in three of four patients. In MIC-treated patients, in vitro lymphocyte reactivity against donor blood cells was restored after B lymphocyte depletion, suggesting a direct pathophysiologic role of regulatory B lymphocytes in donor-specific unresponsiveness.ConclusionsThese results indicate that donor-specific immunosuppression after MIC infusion is long-lasting and associated with a striking increase in regulatory B lymphocytes. Donor-derived MICs appear to be an immunoregulatory cell population that when administered to recipients before transplantation, may exert a beneficial effect on kidney transplants.
引用
收藏
页码:160 / 174
页数:15
相关论文
共 50 条
  • [31] B CELL POPULATION CHANGES AFTER THYMOGLOBULIN INDUCTION IN KIDNEY TRANSPLANT RECIPIENTS
    Sango, Cristina
    Irure, Juan
    Asensio, Esther
    Carlos Ruiz-San Millan, Juan
    Fernandez-Fresnedo, Gema
    Benito, Adalberto
    Lopez-Hoyos, Marcos
    Rodrigo, Emilio
    San Segundo, David
    Sango, Cristina
    Irure, Juan
    Asensio, Esther
    Carlos Ruiz-San Millan, Juan
    Fernandez-Fresnedo, Gema
    Benito, Adalberto
    Lopez-Hoyos, Marcos
    Rodrigo, Emilio
    San Segundo, David
    TRANSPLANT INTERNATIONAL, 2017, 30 : 372 - 372
  • [32] Rapid and long-lasting decrease of T-regulatory cells in patients with myelofibrosis treated with ruxolitinib
    Massa, M.
    Rosti, V.
    Campanelli, R.
    Fois, G.
    Barosi, G.
    LEUKEMIA, 2014, 28 (02) : 449 - 451
  • [33] Rapid and long-lasting decrease of T-regulatory cells in patients with myelofibrosis treated with ruxolitinib
    M Massa
    V Rosti
    R Campanelli
    G Fois
    G Barosi
    Leukemia, 2014, 28 : 449 - 451
  • [34] Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients
    Harden, Paul N.
    Game, David S.
    Sawitzki, Birgit
    van der Net, Jeroen B.
    Hester, Joanna
    Bushell, Andrew
    Issa, Fadi
    Brook, Matthew O.
    Alzhrani, Alaa
    Schlickeiser, Stephan
    Scotta, Cristiano
    Petchey, William
    Streitz, Mathias
    Blancho, Gilles
    Tang, Quizhi
    Markmann, James
    Lechler, Robert I.
    Roberts, Ian S. D.
    Friend, Peter J.
    Hilton, Rachel
    Geissler, Edward K.
    Wood, Kathryn J.
    Lombardi, Giovanna
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (04) : 1603 - 1611
  • [35] Induction of regulatory T cells after prophylactic treatment with photopheresis in renal transplant recipients
    Lamioni, Andrea
    Carsetti, Rita
    Legato, Antonia
    Landolfo, Attilio
    Isacchi, Giancarlo
    Emma, Francesco
    Bottazzo, Gian Franco
    Dello Strologo, Luca
    TRANSPLANTATION, 2007, 83 (10) : 1393 - 1396
  • [36] Relationship between HLA antibodies and regulatory T cells in kidney transplant recipients.
    Crispin, JC
    Rojas, MIV
    Romero, JMB
    Buenrostro, LEM
    Alberú, J
    Varela, JA
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 501 - 501
  • [37] IMMUNOSUPPRESSIVE DRUG PHARMACOKINETICS AND IMMUNE MONITORING IN LONG-TERM KIDNEY TRANSPLANT RECIPIENTS
    Chris, Hope
    Alexander, Fuss
    Toby, Coates P.
    Shilpanjali, Jesudason
    Peter, Heeger
    Robert, Carroll
    IMMUNOLOGY AND CELL BIOLOGY, 2014, 92 (08): : A12 - A13
  • [38] Long-Term Effect of Alemtuzumab Induction on T Cell Memory and T Regulatory Cell (Treg) Subsets in Kidney Transplant Recipients
    Macedo, Camila
    Orkis, Elizabeth
    Elinoff, Beth
    Fedorek, Sheila
    Bentlejewski, Carol
    Lunz, John
    Zeevi, Adriana
    Lakkis, Fadi
    Shapiro, Ron
    Metes, Diana
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 489 - 489
  • [39] Induction Therapies Determine the Distribution of Perforin and Granzyme B Transcripts in Kidney Transplant Recipients
    Pipic, Dino
    Rasmussen, Marianne
    Saleh, Qais W.
    Tepel, Martin
    BIOMEDICINES, 2024, 12 (06)
  • [40] Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virus
    Lamrayah, Myriam
    Charriaud, Fanny
    Desmares, Manon
    Coiffier, Celine
    Megy, Simon
    Colomb, Evelyne
    Terreux, Raphael
    Lucifora, Julie
    Durantel, David
    Verrier, Bernard
    ANTIVIRAL RESEARCH, 2023, 209